Biotechnology
Top daily news stories. Updated every 10 minutes. Click title to go to original website
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’...
A sowing, pruning, and harvesting robot for Synecoculture farming
Synecoculture is a new agricultural method advocated by Dr. Masatoshi Funabashi, senior researcher at Sony Computer Science...
Ruling on Elizabeth Holmes’ prison delay, restitution to Theranos investors pushed back
Ruling on Elizabeth Holmes' prison delay, restitution to Theranos investors pushed back apark Mon, 03/20/2023 - 14:17
‘Super seaweed’ produces natural health compounds and medicine from the sea
Researchers from Tel Aviv University and the Israel Oceanographic and Limnological Research Institute (IOLR) have succeeded...
Plant and microbe matchmaking for better bioenergy crops
Oak Ridge National Laboratory researchers have identified specific proteins and amino acids that could control bioenergy...
Gilead scoops up Nurix’s IRAK4 degrader for up to $445M, plucking first fruit grown from 2019 collab
Gilead scoops up Nurix’s IRAK4 degrader for up to $445M, plucking first fruit grown from 2019 collab mbayer Mon, 03/20/2023...
Stress test kit could boost koala joey survival
Mortality rates of orphaned koala joeys could be greatly reduced by a non-invasive stress test kit being trialed by...
Flush with cash, BioNTech buys into an immunotherapy to rival Yervoy
The COVID-19 vaccine maker is paying $200 million to secure rights to an experimental CTLA-4 inhibitor that privately held...
Athenex’s cash dries up as it faces clinical hold on cancer therapy in wake of patient death
Athenex's cash dries up as it faces clinical hold on cancer therapy in wake of patient death gmasson Mon, 03/20/2023 - 11:25
Illumina, Icahn trade jabs amid looming proxy fight over $8B Grail buy
Illumina, Icahn trade jabs amid looming proxy fight over $8B Grail buy apark Mon, 03/20/2023 - 10:27
BioNTech’s cancer push continues, coughing up $200M for OncoC4’s CTLA-4 antibody
BioNTech's cancer push continues, coughing up $200M for OncoC4's CTLA-4 antibody mbayer Mon, 03/20/2023 - 09:52
Karuna continues to build hype for schizophrenia drug with phase 3 data drop but investors not convinced
Karuna continues to build hype for schizophrenia drug with phase 3 data drop but investors not convinced jwaldron Mon,...
Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years
Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years jwaldron Mon, 03/20/2023 - 07:36
Takeda’s $4B drug clears psoriasis in one-third of patients, laying down marker in bid to challenge BMS
Takeda's $4B drug clears psoriasis in one-third of patients, laying down marker in bid to challenge BMS ntaylor Mon,...
Karuna’s schizophrenia drug succeeds in a second late-stage trial
The results add to a growing body of evidence that Karuna’s drug, known as KarXT, could be a valuable new option for...

hello@diviastrologist.com
phone
(255) 352-6258